Article

New Issue Alert: CURE Spring

We've got a sneak peek at what’s inside CURE®'s spring issue.

Does cannabis have a positive effect on patients with cancer? Although researchers are still conducting studies to gain further evidence, its popularity is driving its legalization for therapeutic use. Our cover story, Flower Power, covers all the angles.

Next, patients with head and neck cancer are Keeping the Options Open. Learn about the less toxic treatment choices that are moving to be used as initial therapy for patients ­— and, hopefully, improving their quality of life.

And, at the age of 21, one woman was told she had the BRCA1 gene mutation, which meant she had a 55 to 85 percent lifetime risk of developing breast cancer. Years later, and after undergoing a double, prophylactic mastectomy, she learned she was misdiagnosed. Her story, plus how she’s Making Lemonade from life’s lemons.

To read these stories and more, visit curetoday.com/publications and click on the latest CURE® cover. Or, ensure you don’t miss a story when you subscribe to new issue alerts. Visit curetoday.com/email-profile for more information.

And, as always, thanks for reading.

Related Videos
1 expert is featured in this series.
Dr. Stephanie Alice Baker
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
1 expert is featured in this series.
Dr. Richard “Rick" Winneker
Related Content